Skip to content

Tandem Diabetes Care TNDM Net Investment in Lease

Net Investment in Lease at other companies

AdaptHealth logo
AdaptHealthAHCO
Abbott logo
AbbottABT
Omnicell logo
OmnicellOMCL
ICU Medical logo
ICU MedicalICUI
CareDx logo
CareDxCDNA
Teladoc Health logo
Teladoc HealthTDOC

Other financials

Income statement

See full
Revenue$247.2M+5.5%
Gross profit$136.8M+15.5%
Operating income-$17.4M+85.6%
Net income-$20.4M+84.4%
EPS (diluted)-$0.30+84.8%

Balance sheet

See full
Cash & equivalents$179.3M+235%
Total debt$734.7M+49.0%
Total equity$132.4M-14.7%
Total assets$1.2B+25.1%

Cash flow

See full
Operating cash flow$11.1M+160%
CapEx$6.3M+111%
Free cash flow$4.8M+123%

Valuation

See full
Market cap$1.08B-19.8%
Enterprise value$1.64B-8.5%
P/S1.1×-0.3×

Profitability

See full
Gross margin54.9%+2.7pp
Operating margin-8.2%-2.9pp
Net margin-9.2%-3.1pp
FCF margin-0.8%-0.4pp

Returns & leverage

See full
Return on equity-65.7%-14.7pp
Debt / equity5.5×+2.4×
Current ratio3.6×+1.3×

Where this comes from

Reported directly by Tandem Diabetes Care in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Tandem Diabetes Care’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Tandem Diabetes Care's net investment in lease.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Tandem Diabetes Care's net investment in lease?
Tandem Diabetes Care (TNDM) reported net investment in lease of $95.74M in Q1 2026.
How has Tandem Diabetes Care's net investment in lease changed year-over-year?
Tandem Diabetes Care's net investment in lease decreased by 5.2% year-over-year, from $101.02M to $95.74M.
What is the long-term trend for Tandem Diabetes Care's net investment in lease?
Over 5 years (2020 to 2025), Tandem Diabetes Care's net investment in lease has grown at a 37.2% compound annual growth rate (CAGR), from $19.77M to $96.17M.